TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-06-12
公報種別公開国際商標公報
国際登録番号1784024
国際登録日2024-02-02
区分第5類(薬剤),第42類(科学・技術),第45類(法律)
商品役務Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment全 30 件を表示, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer’s and Parkinson’s-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.,Research and development in the pharmaceutical and biotechnology fields.,Licensing of intellectual property in the field of biotechnology.
基礎出願番号2023/01381
基礎出願日2023-08-10
基礎出願国IE
出願人Prothena Biosciences Limited
OCRテキストAMCLERUS
OCRテキスト2AMCLERUS
OCRについて
商標ウォッチbot のツイートを見る
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

Anthos Therapeutics, Inc.
OBRYXI
2日前
Anthos Therapeutics, Inc.
XXIABELA
2日前
F2G Ltd
FYMGARVO
2日前
CAPTURE COLLECTIVE, INC.
MIRAD
2日前
VETOQUINOL SA
NOLITCH
2日前
Glanbia Nutritionals Limited
NURSEMATE
2日前
Anthos Therapeutics, Inc.
XXIRIZO
2日前
Anthos Therapeutics, Inc.
LOBEXXI
2日前
Anthos Therapeutics, Inc.
XXIABEL
2日前
Anthos Therapeutics, Inc.
DUXXIBEL
2日前
Anthos Therapeutics, Inc.
XIVIQRO
2日前
Anthos Therapeutics, Inc.
DUVALXI
2日前
Straumann Holding AG
Hemocone
2日前
Novo Nordisk A/S
Ziltanir
2日前
Precigen, Inc.
PAPZIMEOS
2日前
Perelel Inc.
PERELEL
2日前
Cirkul, Inc.
CIRKOLA
2日前
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
正大天晴| CHIATAITIANQING
2日前
Drink LMNT, Inc.
Ε
2日前
FibroGen, Inc.
PET46
2日前
Novo Nordisk A/S
Zilkonir
2日前
Suninflam Ltd.
suninflam
2日前
Straumann Holding AG
Xenooss
2日前
Neurocrine Biosciences, Inc.
2日前
VETOQUINOL SA
ESPRUVA
2日前
ConvaTec Inc.
LEAKDEFENSE
2日前
Boehringer Ingelheim International GmbH
9日前
Bridgebio Pharma, Inc.
9日前
NOVARTIS AG
9日前
NOVARTIS AG
JULRAYSI
9日前
NOVARTIS AG
VYHOPNU
9日前
NOVARTIS AG
ULKEPZO
9日前
NOVARTIS AG
KLYBEZ
9日前
NOVARTIS AG
AFZEYL
9日前
Vascudyne, Inc.
2日前
Boehringer Ingelheim International GmbH
9日前
続きを見る